Biohaven Pharmaceutical Holding Company Ltd (BHVN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: BHVN Exchange: NYS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2019-02-26 2019-02-25 PS Planned sale

Doogan Declan

Non-Executive Director
13,943 -1.3%
45.49
634,267 USD 		13,943 -1.3% 45.49 634,267 USD
2019-02-26 2019-02-25 PS Planned sale

Doogan Declan

Non-Executive Director
100 -0.0%
45.74
4,574 USD 		100 -0.0% 45.74 4,574 USD
2019-02-26 2019-02-25 PS Planned sale

Doogan Declan

Non-Executive Director
20,334 -4.6%
45.25
920,114 USD 		20,334 -4.6% 45.25 920,114 USD
2019-02-26 2019-02-22 PS Planned sale

Doogan Declan

Non-Executive Director
16,050 -3.5%
44.97
721,769 USD 		16,050 -3.5% 44.97 721,769 USD
2019-02-26 2019-02-22 PS Planned sale

Doogan Declan

Non-Executive Director
5,575 -1.2%
44.11
245,913 USD 		5,575 -1.2% 44.11 245,913 USD
2019-02-25 2019-02-21 PS Planned sale

GREGORY JULIA P

Non-Executive Director
12,000 -100.0%
43.56
522,720 USD 		12,000 -100.0% 43.56 522,720 USD
2019-02-20 2019-02-19 PS Planned sale

Doogan Declan

Non-Executive Director
1,400 -0.1%
45.51
63,714 USD 		1,400 -0.1% 45.51 63,714 USD
2019-02-20 2019-02-15 PS Planned sale

Doogan Declan

Non-Executive Director
678 -0.1%
45.42
30,795 USD 		678 -0.1% 45.42 30,795 USD
2019-02-14 2019-02-13 PS Planned sale

Doogan Declan

Non-Executive Director
6,158 -0.5%
44.24
272,430 USD 		6,158 -0.5% 44.24 272,430 USD
2019-02-14 2019-02-12 PS Planned sale

Doogan Declan

Non-Executive Director
33,842 -2.9%
44.32
1,499,877 USD 		33,842 -2.9% 44.32 1,499,877 USD
2019-01-14 2019-01-10 PS Planned sale

Tilton John

Chief Commercial Officer

Officer
10,500 -100.0%
37.67
395,535 USD 		10,500 -100.0% 37.67 395,535 USD
2018-12-06 2018-12-03 PS Planned sale

Doogan Declan

Non-Executive Director
40,000 -3.3%
41.95
1,678,000 USD 		40,000 -3.3% 41.95 1,678,000 USD
2018-06-19 2018-06-15 PS Planned sale

Gentile Kimberly

VP of Operations

Officer
12,500 -100.0%
40.02
500,250 USD 		12,500 -100.0% 40.02 500,250 USD
2018-06-12 2018-06-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
5,629 -2.3%
38.00
213,902 USD 		5,629 -2.3% 38.00 213,902 USD
2018-06-12 2018-06-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
10,647 -4.2%
37.07
394,684 USD 		10,647 -4.2% 37.07 394,684 USD
2018-06-12 2018-06-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
1,377 -0.2%
38.00
52,326 USD 		1,377 -0.2% 38.00 52,326 USD
2018-06-12 2018-06-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
2,604 -0.5%
37.07
96,530 USD 		2,604 -0.5% 37.07 96,530 USD
2018-06-12 2018-06-11 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
100 -0.0%
36.65
3,665 USD 		100 -0.0% 36.65 3,665 USD
2018-06-12 2018-06-11 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
55,907 -18.2%
36.15
2,021,038 USD 		55,907 -18.2% 36.15 2,021,038 USD
2018-06-12 2018-06-11 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
4,409 -1.4%
35.25
155,417 USD 		4,409 -1.4% 35.25 155,417 USD
2018-06-12 2018-06-11 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
13,858 -2.4%
36.16
501,105 USD 		13,858 -2.4% 36.16 501,105 USD
2018-06-12 2018-06-11 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
1,218 -0.2%
35.25
42,935 USD 		1,218 -0.2% 35.25 42,935 USD
2018-06-12 2018-06-08 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
6,735 -2.1%
36.01
242,527 USD 		6,735 -2.1% 36.01 242,527 USD
2018-06-12 2018-06-08 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
1,671 -0.3%
36.01
60,173 USD 		1,671 -0.3% 36.01 60,173 USD
2018-06-07 2018-06-07 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
2,003 -0.6%
36.01
72,128 USD 		2,003 -0.6% 36.01 72,128 USD
2018-06-07 2018-06-07 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
497 -0.1%
36.01
17,897 USD 		497 -0.1% 36.01 17,897 USD
2018-06-07 2018-06-06 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
13,608 -4.0%
36.01
490,024 USD 		13,608 -4.0% 36.01 490,024 USD
2018-06-07 2018-06-06 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
3,375 -0.6%
36.01
121,534 USD 		3,375 -0.6% 36.01 121,534 USD
2018-06-07 2018-06-05 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
4,962 -1.4%
36.02
178,731 USD 		4,962 -1.4% 36.02 178,731 USD
2018-06-07 2018-06-05 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
1,400 -0.2%
36.00
50,400 USD 		1,400 -0.2% 36.00 50,400 USD
2018-06-06 2018-06-05 PS Planned sale

Doogan Declan

Non-Executive Director
300 -0.0%
36.00
10,800 USD 		300 -0.0% 36.00 10,800 USD
2018-06-06 2018-06-05 PS Planned sale

Doogan Declan

Non-Executive Director
49,463 -4.0%
35.41
1,751,485 USD 		49,463 -4.0% 35.41 1,751,485 USD
2018-06-06 2018-06-04 PS Planned sale

Doogan Declan

Non-Executive Director
39,453 -3.1%
35.05
1,382,828 USD 		39,453 -3.1% 35.05 1,382,828 USD
2018-06-01 2018-06-01 PS Planned sale

Doogan Declan

Non-Executive Director
83,898 -6.1%
35.04
2,939,786 USD 		83,898 -6.1% 35.04 2,939,786 USD
2018-06-01 2018-06-01 PS Planned sale

Coric Vlad

Chief Executive Officer

Executive Director
5,229 -1.0%
35.04
183,224 USD 		5,229 -1.0% 35.04 183,224 USD
2018-06-01 2018-06-01 PS Planned sale

Coric Vlad

Chief Executive Officer

Executive Director
8,611 -1.6%
35.04
301,729 USD 		8,611 -1.6% 35.04 301,729 USD
2018-06-01 2018-05-31 PS Planned sale

Doogan Declan

Non-Executive Director
26,044 -1.9%
35.01
911,800 USD 		26,044 -1.9% 35.01 911,800 USD
2018-06-01 2018-05-31 PS Planned sale

Coric Vlad

Chief Executive Officer

Executive Director
18,971 -3.5%
35.01
664,175 USD 		18,971 -3.5% 35.01 664,175 USD
2018-06-01 2018-05-31 PS Planned sale

Coric Vlad

Chief Executive Officer

Executive Director
15,648 -2.8%
35.01
547,836 USD 		15,648 -2.8% 35.01 547,836 USD
2018-06-01 2018-05-30 PS Planned sale

Doogan Declan

Non-Executive Director
842 -0.1%
35.00
29,470 USD 		842 -0.1% 35.00 29,470 USD
2018-06-01 2018-05-30 PS Planned sale

Coric Vlad

Chief Executive Officer

Executive Director
800 -0.1%
35.00
28,000 USD 		800 -0.1% 35.00 28,000 USD
2018-06-01 2018-05-30 PS Planned sale

Coric Vlad

Chief Executive Officer

Executive Director
741 -0.1%
35.00
25,935 USD 		741 -0.1% 35.00 25,935 USD
2018-05-30 2018-05-30 PS Planned sale

Engelhart James

Chief Financial Officer

Officer
5,000 -100.0%
35.00
175,000 USD 		5,000 -100.0% 35.00 175,000 USD
2018-05-14 2018-05-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
1,520 -0.4%
27.52
41,830 USD 		1,520 -0.4% 27.52 41,830 USD
2018-05-14 2018-05-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
26,480 -7.0%
26.78
709,134 USD 		26,480 -7.0% 26.78 709,134 USD
2018-05-14 2018-05-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
380 -0.1%
27.52
10,458 USD 		380 -0.1% 27.52 10,458 USD
2018-05-14 2018-05-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
6,620 -1.1%
26.78
177,284 USD 		6,620 -1.1% 26.78 177,284 USD
2018-05-09 2018-05-07 PS Planned sale

Engelhart James

Chief Financial Officer

Officer
2,500 -100.0%
27.67
69,175 USD 		2,500 -100.0% 27.67 69,175 USD
2018-04-12 2018-04-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
80 -0.0%
25.81
2,065 USD 		80 -0.0% 25.81 2,065 USD
2018-04-12 2018-04-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
10,880 -2.8%
25.39
276,243 USD 		10,880 -2.8% 25.39 276,243 USD
2018-04-12 2018-04-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
17,040 -4.2%
24.19
412,198 USD 		17,040 -4.2% 24.19 412,198 USD
2018-04-12 2018-04-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
20 -0.0%
25.81
516 USD 		20 -0.0% 25.81 516 USD
2018-04-12 2018-04-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
2,720 -0.5%
25.39
69,061 USD 		2,720 -0.5% 25.39 69,061 USD
2018-04-12 2018-04-10 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
4,260 -0.7%
24.19
103,049 USD 		4,260 -0.7% 24.19 103,049 USD
2018-03-14 2018-03-12 PS Planned sale

Berman Robert

Chief Medical Officer
2,360 -0.6%
30.68
72,405 USD 		2,360 -0.6% 30.68 72,405 USD
2018-03-14 2018-03-12 PS Planned sale

Berman Robert

Chief Medical Officer
25,640 -5.9%
30.06
770,738 USD 		25,640 -5.9% 30.06 770,738 USD
2018-03-14 2018-03-12 PS Planned sale

Berman Robert

Chief Medical Officer
590 -0.1%
30.68
18,101 USD 		590 -0.1% 30.68 18,101 USD
2018-03-14 2018-03-12 PS Planned sale

Berman Robert

Chief Medical Officer
6,410 -1.1%
30.06
192,685 USD 		6,410 -1.1% 30.06 192,685 USD
2018-03-05 2018-03-01 PS Planned sale

Gentile Kimberly

VP of Operations
2,200 -100.0%
33.44
73,568 USD 		2,200 -100.0% 33.44 73,568 USD
2018-03-05 2018-03-01 PS Planned sale

Gentile Kimberly

VP of Operations
2,800 -56.0%
32.42
90,776 USD 		2,800 -56.0% 32.42 90,776 USD
2018-02-23 2018-02-21 PS Planned sale

Engelhart James

Chief Financial Officer

Officer
538 -15.0%
29.60
15,925 USD 		538 -15.0% 29.60 15,925 USD
2018-02-14 2018-02-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
18,544 -4.1%
30.69
569,115 USD 		18,544 -4.1% 30.69 569,115 USD
2018-02-14 2018-02-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
9,456 -2.1%
29.88
282,545 USD 		9,456 -2.1% 29.88 282,545 USD
2018-02-14 2018-02-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
4,636 -0.8%
30.69
142,279 USD 		4,636 -0.8% 30.69 142,279 USD
2018-02-14 2018-02-12 PS Planned sale

Berman Robert

Chief Medical Officer

Officer
2,364 -0.4%
29.88
70,636 USD 		2,364 -0.4% 29.88 70,636 USD
2018-02-02 2018-02-01 PS Planned sale

Gentile Kimberly

VP of Operations

Officer
300 -100.0%
33.99
10,197 USD 		300 -100.0% 33.99 10,197 USD
2018-02-02 2018-02-01 PS Planned sale

Gentile Kimberly

VP of Operations

Officer
1,348 -81.8%
33.53
45,198 USD 		1,348 -81.8% 33.53 45,198 USD
2018-02-02 2018-02-01 PS Planned sale

Gentile Kimberly

VP of Operations

Officer
3,352 -67.0%
32.37
108,504 USD 		3,352 -67.0% 32.37 108,504 USD
2018-02-02 2018-01-31 PS Planned sale

Bailey Gregory

Non-Executive Director
23,320 -0.9%
34.32
800,342 USD 		23,320 -0.9% 34.32 800,342 USD
2018-02-02 2018-01-31 PS Planned sale

Bailey Gregory

Non-Executive Director
18,280 -0.7%
33.42
610,918 USD 		18,280 -0.7% 33.42 610,918 USD
2018-02-02 2018-01-31 PS Planned sale

Bailey Gregory

Non-Executive Director
8,400 -0.3%
32.63
274,092 USD 		8,400 -0.3% 32.63 274,092 USD
2018-01-25 2018-01-23 PS Planned sale

Bailey Gregory

Non-Executive Director
16,000 -0.6%
32.79
524,640 USD 		16,000 -0.6% 32.79 524,640 USD
2018-01-24 2018-01-23 PS Planned sale

PORTAGE BIOTECH INC.

former 10% owner
24,277 -30.8%
331,520.00
8,048,311,040 USD 		24,277 -30.8% 331,520.00 8,048,311,040 USD
2018-01-24 2018-01-22 PS Planned sale

Engelhart James

Chief Financial Officer

Officer
10,000 -73.7%
32.50
325,000 USD 		10,000 -73.7% 32.50 325,000 USD
2018-01-23 2018-01-22 PS Planned sale

Bailey Gregory

Non-Executive Director
9,000 -0.4%
32.51
292,590 USD 		9,000 -0.4% 32.51 292,590 USD